Institutional members access full text with Ovid®

Share this article on:

Fatal Disseminated Histoplasmosis and Aspergillosis Coinfection During Adalimumab Therapy in a Patient From New York State

El Khoury, Marc Y. MD*; Yalamanchili, Kiran K. MD; Patel, Roshan K. MD; Braun, Alex MD; Lerner, Robert G. MD; Wolf, David C. MD§; Wormser, Gary P. MD*

Infectious Diseases in Clinical Practice: March 2011 - Volume 19 - Issue 2 - p 121-123
doi: 10.1097/IPC.0b013e3181e928cf
Case Reports

We report a fatal case of disseminated histoplasmosis and aspergillosis coinfection associated with tumor necrosis factor α inhibitor therapy in a patient from New York State with remote exposure to an area endemic for histoplasma.

From the *Divisions of Infectious Diseases, and †Hematology and Oncology,Department of Medicine, New York Medical College, ‡Department of Pathology, New York Medical College, and §Division of Gastroenterology and Hepatobiliary Diseases, Department of Medicine, New York Medical College, Valhalla, NY.

Correspondence to: Marc El Khoury, MD, Division of Infectious Diseases, New York Medical College, Munger Pavilion Room 245, Valhalla, NY 10595. E-mail:

The authors have no funding or conflicts of interest to disclose.

© 2011 Lippincott Williams & Wilkins, Inc.